![]() |
|
|
Forward to a colleague |
||
Access Full Stories Drug developers have a new target to aim at in the fight against obesity after the discovery that a certain protein in the body stimulates the formation of fat cells... Read Best biopharma bosses There have been a few changes in the top ten employers according to leading journal Science's annual survey of the best companies to work for in the biotech, biopharma, pharmaceutical and related industries... Read Ventana to help develop pathway for companion diagnostics The Critical Path Institute (C-Path) and diagnostics expert Ventana Medical Systems are collaborating to develop a standard submission route for targeted therapies and companion diagnostics... Read It's a NanoDrop for Thermo Fisher Scientific Thermo Fisher Scientific has acquired micro-volume UV-Vis (ultra violet visible) instrument manufacturer NanoDrop Technologies for an undisclosed amount... Read Drugs moving into the clinic: 31 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read |
||||||||||||||
All News Headlines for: October | September | August |
||||||||||||||
Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here | ||||||||||||||
|
Related Industry News Boehringer UK plant 'couldn't compete' Boehringer Ingelheim has been forced to announce the planned closure of a UK manufacturing site as a result of pricing pressures that mean the firm is unable to produce unit dose vials (UDVs) at the site cost-effectively... Read Cough and cold products for under-twos recalled Several big drug-makers are voluntarily recalling some of their cough and cold products for under-two-year-olds in the US as a precautionary measure against overdosing on the drugs... Read Patch-based travel vaccine looks good The first vaccine for travellers' diarrhoea is looking promising after the announcement of Phase II results... Read UCB opens Irish facility UCB is a wee bit excited after the opening of its newly expanded Irish facility, which will manufacture the company's overactive bladder drug, anticipated to be launched within the next two years... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||